Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
10/2003
10/30/2003WO2003088919A2 Compositions and methods for diagnostics and therapeutics for hydrocephalus
10/30/2003WO2003088916A2 Compositions and methods for the acceleration of protein secretion dynamics
10/30/2003WO2003088904A2 Screening and therapeutic methods for treating circadian rhythm disorders
10/30/2003WO2003088760A1 Canola protein isolate compositions
10/30/2003WO2003088749A1 Oil body associated protein compositions and methods of use thereof for reducing the risk of cardiovascular disease
10/30/2003WO2003088738A1 Regulated ethylene sensitivity to control flower longevity in a plant
10/30/2003WO2003073841A3 Transgenic non-human mammals expressing constitutively activated tyrosine kinase receptors
10/30/2003WO2003066652A3 Jlp cytoplasmic scaffolding protein and nucleic acids encoding it
10/30/2003WO2003063725A3 Methods of preventing and treating flavivirus infection in animals
10/30/2003WO2003060146A3 Compositions and methods relating to urinary specific genes and proteins
10/30/2003WO2003056295A3 Enterococcal virulence factors
10/30/2003WO2003053996A3 Modular peptide-based reagent
10/30/2003WO2003052095A3 Use of a lysolipid for the preparation of a composition for transfection of a polynucleotide into a cell
10/30/2003WO2003050233A3 Gene promoters
10/30/2003WO2003047421A3 Methods and reagents for diagnosis and treatment of diabetes
10/30/2003WO2003046004A3 Macroglobulin biopolymer markers indicative of insulin resistance
10/30/2003WO2003046000A3 Apolipoprotein biopolymer markers predictive of insulin resistance
10/30/2003WO2003040332A3 Neuroglobin is up-regulated by and protects neuronsfrom hypoxic-ischemic injury
10/30/2003WO2003040310A3 Novel epidermal growth factor protein and gene, and methods of use therefor
10/30/2003WO2003039491A8 Novel isoforms of vascular endothelial cell growth inhibitor
10/30/2003WO2003038434A3 Serological assay for neospora caninum
10/30/2003WO2003035849A3 Methods for gene transfer using pseudotyped lentiviruses
10/30/2003WO2003035693A3 Crystals of cytochrome p450 2c9, structures thereof and their use
10/30/2003WO2003035692A3 Modified peptides and their uses
10/30/2003WO2003034903A3 Psma antibodies and protein multimers
10/30/2003WO2003033703A3 Human gtp-activator protein for rab-like gtpase
10/30/2003WO2003032899A3 Methods and materials for targeting and affecting selected cells
10/30/2003WO2003031612A3 Method for determining cell cycle position
10/30/2003WO2003031588A3 Hepatitis c virus vaccine
10/30/2003WO2003031568A3 Intracellular signaling molecules
10/30/2003WO2003031469A3 Means for improving immune response
10/30/2003WO2003029482A3 Diagnosing, treating, and preventing cancer using cables
10/30/2003WO2003029428A3 Use of calmodulin kinase ii inhibitors to treat myocardial dysfunction in structural heart disease
10/30/2003WO2003029274A3 Paramyxoviruses as gene transfer vectors to lung cells
10/30/2003WO2003028527A3 Diagnostic or therapeutic somatostatin or bombesin analog conjugates and uses thereof
10/30/2003WO2003027143A3 Gene and protein relating to hepatocellular carcinoma
10/30/2003WO2003020840A9 Methods for purifying insoluble bone gelatin
10/30/2003WO2003018821A3 Compositions and methods for treating neurodegenerative diseases
10/30/2003WO2003018619A3 Antimicrobial and anti-inflammatory peptides
10/30/2003WO2003016549A3 Nucleic-acid associated proteins
10/30/2003WO2003014310A3 Dna encoding rat bombesin receptor subtype-3 (brs-3) and uses thereof
10/30/2003WO2003014150A3 Fusion proteins for insect control
10/30/2003WO2003006668A3 Haptoglobin Derived Antioxidants
10/30/2003WO2003000877A3 A soluble complex comprising a retroviral surface glycoprotein
10/30/2003WO2003000728A3 Testis protein, zsig86
10/30/2003WO2003000717A3 Identification of ses-3 (spr-5) in c. elegans and the uses of the same
10/30/2003WO2002103362A3 Cancer associated protein
10/30/2003WO2002102229A3 Diagnosing tumorigenicity and determining resistance to anticancer therapy
10/30/2003WO2002099117A3 Nucleic acid regulatory sequences and uses therefor
10/30/2003WO2002098919A3 Method for apo ciii measurement in apob and non apob containing particles
10/30/2003WO2002097030A3 Peptides derived from neural thread proteins and their medical use
10/30/2003WO2002094876A3 Methods and compositions for treating respiratory mucin production associated disease conditions
10/30/2003WO2002094851A3 Peptide vaccines against group a streptococci
10/30/2003WO2002090526A3 Human secreted proteins
10/30/2003WO2002086122A3 Protein-protein interactions in adipocytes
10/30/2003WO2002085941A3 Modified interferon alpha with reduced immunogenicity
10/30/2003WO2002083945A3 Diagnosis and treatment of cancer: i
10/30/2003WO2002083906A9 Mhc tetramers
10/30/2003WO2002081722A3 Process for the production of l-amino acids using strains of the family enterobacteriaceae that contain an attenuated acea gene
10/30/2003WO2002081721A3 Process for the production of l-amino acids using strains of the family enterobacteriaceae that contain an attenuated dgsa gene
10/30/2003WO2002081698A3 Process for the production of l-amino acids using strains of the family enterobacteriaceae that contain an attenuated frur gene
10/30/2003WO2002079247A3 Intimins in the prevention or treatment of infections:ii
10/30/2003WO2002074803A3 Regulation of human icos v protein
10/30/2003WO2002074788A3 TRP2 ISOFORM TRP2-6b CONTAINING HLA-A2-RESTRICTED EPITOPES
10/30/2003WO2002072851A3 Lentiviral packaging constructs
10/30/2003WO2002070663A3 Isolated human enzyme proteins, nucleic acid molecules encoding human enzyme proteins, and uses thereof
10/30/2003WO2002070547A8 Template-fixed peptidomimetics with antimicrobial activity
10/30/2003WO2002068693A3 Method for the systematic discovery of genes and genes discovered thereby
10/30/2003WO2002068645A3 Compositions and methods relating to breast specific genes and proteins
10/30/2003WO2002068610A3 Compositions and methods for affecting virulence determinants in bacteria
10/30/2003WO2002066612A3 Novel substitution mutant receptors and their use in a nuclear receptor-based inducible gene expression system
10/30/2003WO2002064784A3 Yeast strain of saccharomyces cerevisiae with functional expression of a glut transporter
10/30/2003WO2002062833A3 Modified leptin with reduced immunogenicity
10/30/2003WO2002061430A3 Methods and reagents for treating autoimmune disorders
10/30/2003WO2002059283A3 Nucleic acid modification enzymes
10/30/2003WO2002055704A3 Proteins, polynucleotides encoding them and methods of using the same
10/30/2003WO2002034783A3 Transmembrane proteins
10/30/2003WO2002030973A9 The caveolin-1 gene and polypeptide encoded thereby and methods of use thereof
10/30/2003WO2002028175A9 Transgenic mouse for targeted recombination mediated by modified cre-er
10/30/2003WO2002026826A3 Proteins and nucleic acids encoding same
10/30/2003WO2002026817A3 33521, a human guanine nucleotide exchange family member and uses thereof
10/30/2003WO2002022821A3 Antimicrobial peptides and methods of use
10/30/2003WO2002022819A3 Calcium binding proteins
10/30/2003WO2002018583A9 Modified polypeptides stabilized in a desired conformation and methods for producing same
10/30/2003WO2002017711A9 Therapeutics and diagnostics based on a novel signal transduction system in platelets
10/30/2003WO2002010414A9 Expression of biologically active polypeptides in duckweed
10/30/2003WO2002008447A3 Nucleic acids and methods for detecting viral infection, uncovering anti-viral drug candidates and determining drug resistance of viral isolates
10/30/2003WO2002002638A3 Methods for treating rheumatic diseases using a soluble ctla4 molecule
10/30/2003WO2001090302A3 Compositions and methods for production of rna viruses and rna virus-based vector particles
10/30/2003US20030204870 Alteration of oil traits in plants
10/30/2003US20030204869 Method to control the ripening of papaya fruit and confer disease resistance to papaya plants
10/30/2003US20030204868 Pseudomonas avr and hop proteins, their encoding nucleic acids, and use thereof
10/30/2003US20030204867 Nucleotide sequences coding transport protein for generating transgenic crop plants with adjusted nitrogen metabolism and which grow on acidic soils; increased biomass production
10/30/2003US20030204864 Stable plastid transformation and expression vector for transferring target nucleotide sequences into plants for mass production of affordable vaccines and pharmaceutical agents
10/30/2003US20030204863 Nav2 channel gene-deficient non-human animals
10/30/2003US20030204859 Animal model of polyglutamine toxicity, methods of use, and modulators of polyglutamine toxicity
10/30/2003US20030204097 For inhibiting retroviral proteases, such as human immunodeficiency virus (HIV) protease
10/30/2003US20030204074 Streptococcus pneumoniae 37-kDa surface adhesin a protein
10/30/2003US20030204073 Identifying an allosteric modulator/antagonist of g-protein coupled receptors for treatment of metabolic disorders
10/30/2003US20030204072 Comprises receptor protein tyrosine kinase (rPTK) for diagnosing and treating kidney or neurodegenerative diseases
1 ... 1500 1501 1502 1503 1504 1505 1506 1507 1508 1509 1510 1511 1512 1513 1514 1515 1516 1517 1518 1519 1520 ... 2916